Reported results
- Net loss was $21.2 million, or $0.89 per share, for the quarter ended September 30, 2026, compared to a net loss of $6.6 million, or $1.68 per share, for the quarter ended September 30, 2025.
- Cash, cash equivalents and investments were $32.3 million as of September 30, 2026, compared to $88.3 million as of December 31, 2025.
- Net cash used in operations was $18.98 million for the quarter ended September 30, 2026, compared to $4.7 million for the quarter ended September 30, 2025.
- Research and development expenses were $14.6 million for the quarter ended September 30, 2026, compared to $2.8 million for the quarter ended September 30, 2025.
- General and administrative expenses were $6.9 million for the quarter ended September 30, 2026, compared to $4.0 million for the quarter ended September 30, 2025.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-16 (8-K, Item 2.02). Read the original filing on sec.gov.
